S100B and infection: The combination comprising polypeptide antigens derived from gp41e, p31, p17, and Nef showed a good sensitivity of 98.5% to the majority of HIV-1 clades and throughout all stages of infection and a specificity of 98.1% in uninfected healthy controls and 97.1% at 12 weeks after full vaccination.